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Abstract
Background: The single nucleotide polymorphism (SNP) of peroxisome proliferator-activated receptor delta
(PPARD) gene affects serum lipid profiles, but to what extent alcohol consumption interferes with this association
remains unknown. The present study was undertaken to compare the association of PPARD +294T > C (rs2016520)
polymorphism and serum lipid levels in the nondrinkers and drinkers.
Methods: A total of 685 unrelated nondrinkers and 497 drinkers aged 15-82 were randomly selected from our
previous stratified randomized cluster samples. Genotyping of the PPARD +294T > C was performed by polymerase
chain reaction and restriction fragment length polymorphism. Interactions of the PPARD +294T > C genotypes and
alcohol consumption on serum lipid levels were detected by using a factorial regression analysis after controlling
for potential confounders.
Results: The levels of triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), apolipoprotein (Apo) A1, and the
ratio of ApoA1 to ApoB were higher in drinkers than in nondrinkers (P < 0.05-0.001). There were no significant
differences in the levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and ApoB between the two
groups (P > 0.05 for all). The frequencies of TT, TC and CC genotypes were 56.0%, 36.4% and 7.6% in nondrinkers, and
57.2%, 38.0% and 4.8% in drinkers (P > 0.05); respectively. The frequencies of T and C alleles were 74.2% and 25.8% in
nondrinkers, and 76.2% and 23.8% in drinkers (P > 0.05); respectively. There was also no significant difference in the
genotypic and allelic frequencies between males and females in both groups (P > 0.05 for all). The levels of TC in
nondrinkers were different among the three genotypes (P = 0.01), the C allele carriers had higher serum TC levels than
the C allele noncarriers. The levels of all seven lipid traits in drinkers were not different among the three genotypes (P >
0.05 for all). The interactions of PPARD +294T > C genotypes and alcohol consumption on serum lipid levels were not
detected in the drinkers (P> 0.05 for all). Multiple linear regression analysis showed that serum TC, HDL-C, LDL-C, ApoA1,
and ApoB levels were correlated with genotypes in drinkers but not in nondrinkers (P < 0.05-0.01).
Conclusions: These results suggest that the great majority of our study populations are beneficial from alcohol
consumption. But there is no interaction between the PPARD +294T > C genotypes and alcohol consumption on
serum lipid levels in the drinkers.
Introduction
Abnormalities in lipid metabolism such as elevated total
cholesterol (TC), triglyceride (TG), low-density lipopro-
tein cholesterol (LDL-C) and apolipoprotein (Apo) B
levels, together with decreased high-density lipoprotein
cholesterol (HDL-C), and ApoA1 levels, are considered
as major risk factors for coronary artery disease (CAD)
[1-4]. It is well known that serum lipid levels are modu-
lated by multiple environmental and genetic factors and
their interactions [5-11]. Numerous studies have evalu-
ated the influence of alcohol consumption on CAD and
serum lipid concentrations. Low to middle amounts of
alcohol when taken on a regular basis have been shown
to protect against CAD and death [12,13], whereas
heavy drinking constitutes a severe risk condition. These
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increase in HDL-C and ApoA1 [14-17]. A decrease in
LDL-C with increased alcohol intake has also been
reported in some studies [18]. However, alcohol in
doses > 30 g/day in both sexes can augment serum TG
levels [15,19].
Peroxisome proliferator-activated receptors (PPARs) are
ligand-activated nuclear hormone receptors that act as
transcriptional regulators and are involved in glucose and
lipid metabolism. Three different PPARs, PPAR-alpha
(PPARA), PPAR-gamma (PPARG), and PPAR-delta
(PPARD) have been characterized [20], and they are dis-
tinguished from each other by tissue distribution and cell
activation. PPARA is mainly expressed in liver, muscle,
kidney and heart, PPARG is most abundant in adipocytes,
intestinal cells and macrophages and PPARD is expressed
in many tissues [21-23]. PPARs are encoded by separate
genes and characterized by distinct tissue and develop-
mental distribution patterns. The PPARD gene was
mapped to 6p21.2-p21.1 with 11 exons spanning 35 Kbp
and is expressed ubiquitously [24]. The PPARD +294T >
C (rs2016520) polymorphism in the 5’-untranslated region
in exon 4 of the PPARD gene is located 87 nucleotides
upstream of the start codon. It was shown that the single
nucleotide polymorphism (SNP) influenced binding of Sp-
1 resulting in higher transcriptional activity for the rare C
allele than the common T allele [25]. Several previous stu-
dies have showed that the PPARD +294T > C polymorph-
ism was associated with modifications of serum lipid
concentrations in the general population and the risk of
CAD [25-34] in dyslipidemic women and hypercholestero-
lemic men and cholesterol metabolites in Alzheimer’s dis-
ease patients [35]. But the results are inconsistent in
diverse populations [33,36]. Furthermore, little is known
about the interactions of PPARD +294T > C polymorph-
ism and alcohol consumption on serum lipid concentra-
tions. Therefore, the aim of the present study was to
compare the association of PPARD +294T > C
(rs2016520) polymorphism and serum lipid levels in the
nondrinkers and drinkers.
Materials and methods
Study population
A total of 685 unrelated nondrinkers and 497 drinkers
were randomly selected from our previous stratified ran-
domized cluster samples [5,6]. The age of the subjects
ranged from 15 to 82 years, with an average age of
43.46 ± 16.50 years. All of the subjects were rural agri-
cultural workers. The subjects with evidence of diseases
related to atherosclerosis, CAD and diabetes have been
excluded. None of them had been treated with b-adre-
nergic blocking agents and lipid-lowering drugs such as
statins or fibrates. The present study was approved by
the Ethics Committee of the First Affiliated Hospital,
Guangxi Medical University. Informed consent was
obtained from all subjects.
Epidemiological survey
The survey was carried out using internationally standar-
dized methods [37]. Information on demographics, socio-
economic status, and lifestyle factors was collected with
standardized questionnaires. The alcohol information
included questions about the number of liangs (about 50
g) of rice wine, corn wine, rum, beer, or liquor consumed
during the preceding 12 months. Alcohol consumption
was categorized into groups of grams of alcohol per day:
<2 5a n d≥ 25. Smoking status was categorized into
groups of cigarettes per day: < 20 and ≥ 20. At the physi-
cal examination, several parameters including height,
weight, and waist circumference were measured. Sitting
blood pressure was measured three times with the use of
a mercury sphygmomanometer after the subjects had a
5-minute rest, and the average of the three measure-
ments was used for the level of blood pressure. Systolic
blood pressure was determined by the first Korotkoff
sound, and diastolic blood pressure by the fifth Korotkoff
sound. Body weight, to the nearest 50 grams, was mea-
sured using a portable balance scale. Subjects were
weighed without shoes and in a minimum of clothing.
Height was measured, to the nearest 0.5 cm, using a por-
table steel measuring device. From these two measure-
ments body mass index (BMI, kg/m
2) was calculated.
Biochemical analysis
A venous blood sample of 5 mL was obtained from all
subjects after at least 12 hours of fasting. A part of the
sample (2 mL) was collected into glass tubes and
allowed to clot at room temperature, and used to deter-
mine serum lipid levels. Another part of the sample (3
mL) was transferred to tubes with anticoagulate solution
(4.80 g/L citric acid, 14.70 g/L glucose, and 13.20 g/L
tri-sodium citrate) and used to extract DNA. The levels
of TC, TG, HDL-C, and LDL-C in samples were deter-
mined by enzymatic methods with commercially avail-
able kits, Tcho-1, TG-LH (RANDOX Laboratories Ltd.,
Ardmore, Diamond Road, Crumlin Co. Antrim, United
Kingdom, BT29 4QY), Cholestest N HDL, and Cholest-
est LDL (Daiichi Pure Chemicals Co., Ltd., Tokyo,
Japan); respectively. Serum ApoA1 and ApoB levels
were detected by the immunoturbidimetric immunoas-
say using a commercial kit (RANDOX Laboratories
Ltd.). All determinations were performed with an autoa-
nalyzer (Type 7170A; Hitachi Ltd., Tokyo, Japan) in our
Clinical Science Experiment Center [5,6].
DNA amplification and genotyping
Genomic DNA was isolated from peripheral blood leu-
kocytes using the phenol-chloroform method [7].
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was performed by polymerase chain reaction and restric-
tion fragment length polymorphism (PCR-RFLP) [31].
PCR amplification was performed using 5’-CATGGTAT
AGCACTGCAGGAA-3’ and 5’-CTTCCTCCTGTG
GCTGCTC-3’ (Sangon, Shanghai, People’sR e p u b l i co f
China) as the forward and reverse primer pairs; respec-
tively. Each amplification reaction was performed using
100 ng genomic DNA in 25 μL of reaction mixture con-
sisting of 1.0 μL of each primer (10 μmol/L), 12.5 μL2
× Taq PCR MasterMix (constituent: 0.1 U Taq polymer-
ase/μL, 500 μMd N T Pe a c ha n dP C Rb u f f e r ).A f t e r
initial denaturizing at 95°C for 5 min, the reaction mix-
ture was subjected to 30 cycles of 45 s denaturation at
94°C, 45 s annealing at 62°C and extension 45 s at 72°C,
followed by a final 8 min extension at 72°C. After elec-
trophoresis on a 2.0% agarose gel with 0.5 μg/mL ethi-
dium bromide, the amplification products were
visualized under ultraviolet light. Then 5 U of BslI
restriction enzyme was added directly to the PCR pro-
ducts (6 μL) and digested at 55°C overnight. After
restriction enzyme digestion of the amplified DNA, the
genotypes were identified by electrophoresis on 2.5%
agarose gels and visualized with ethidium-bromide stain-
ing ultraviolet illumination. The genotypes were scored
by an experienced reader blinded to epidemiological
data and serum lipid levels.
Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C,
ApoA1, ApoB levels, and the ratio of ApoA1 to ApoB in
our Clinical Science Experiment Center were 3.10-5.17,
0.56-1.70, 0.91-1.81, 2.70-3.20 mmol/L, 1.00-1.78, 0.63-
1.14 g/L, and 1.00-2.50; respectively. The individuals
with TC > 5.17 mmol/L and/or TG > 1.70 mmol/L were
defined as hyperlipidemic [5,6]. Hypertension was
defined as an average systolic blood pressure of 140
mmHg or greater and/or an average diastolic blood
pressure of 90 mmHg or greater, and/or self-reported
pharmacological treatment for hypertension within the 2
weeks prior to the interview [38,39]. Normal weight,
overweight and obesity were defined as a BMI < 24, 24-
28, and > 28 kg/m
2; respectively [40].
Statistical analyses
Quantitative variables were expressed as mean ± stan-
dard deviation (serum TG levels were presented as med-
ians and interquartile ranges). Qualitative variables were
expressed as percentages. Allele frequency was deter-
mined via direct counting, and the standard goodness-
of-fit test was used to test the Hardy-Weinberg equili-
brium. Difference in genotype distribution between the
groups was obtained using the chi-square test. The dif-
ference in general characteristics between nondrinkers
and drinkers tested by the Student’s unpaired t-test. The
association of genotypes and serum lipid parameters was
tested by analysis of covariance (ANCOVA). Sex, age,
BMI, blood pressure, and cigarette smoking were
adjusted for the statistical analysis. In order to evaluate
the association of serum lipid parameters and genotypes
(TT = 1, TC = 2, CC = 3), multiple linear regression
analysis with stepwise modeling was also performed in
the combined population of nondrinkers and drinkers,
nondrinkers, and drinkers; respectively. All statistical
analyses were done with the statistical software package
S P S S1 3 . 0( S P S SI n c . ,C h i c a g o ,I l l i n o i s ) .AP value of
less than 0.05 was considered statistically significant.
Results
General characteristics between nondrinkers and drinkers
Table 1 gives the general characteristics between nondrin-
kers and drinkers. The ratio of male to female, the levels
of mean age, body height, weight, BMI, waist circumfer-
ence, systolic blood pressure and diastolic blood pressure,
and the percentages of subjects who smoked cigarettes
were higher in drinkers than in nondrinkers (P < 0.001 for
all). There was no significant difference in the levels of
pulse pressure between the two groups (P > 0.05).
Serum lipid levels between nondrinkers and drinkers
The levels of serum lipid parameters between nondrin-
kers and drinkers are also shown in Table 1. The levels
of TG, HDL-C, ApoA1, and the ratio of ApoA1 to
ApoB were higher in drinkers than in nondrinkers (P <
0.05-0.001). There were no significant differences in the
levels of TC, LDL-C and ApoB between the two groups
(P > 0.05 for all).
Results of electrophoresis and genotyping
After the genomic DNA of the samples was amplified by
PCR and imaged by 2.0% agarose gel electrophoresis, the
PCR products of 269 bp nucleotide sequences could be
found in all samples. The genotypes identified were
named according to the presence or absence of the
enzyme restriction sites, when a T to C transversion at
+294 locus of the PPARD. The presence of the cutting
site indicates the C allele, whereas its absence indicates
the T allele (cannot be cut). Thus, the TT genotype is
homozygote for the absence of the site (band at 269 bp),
TC genotype is heterozygote for the absence and pre-
sence of the site (bands at 269-, 167- and 102-bp), and
CC genotype is homozygote for the presence of the site
(bands at 167- and 102- bp). The genotype distribution
was consistent with the Hardy-Weinberg equilibrium.
Genotypic and allelic frequencies
The genotypic and allelic frequencies of PPARD +294T >
C polymorphism in the nondrinkers and drinkers are
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otypes were 56.0%, 36.4% and 7.6% in nondrinkers, and
57.2%, 38.0% and 4.8% in drinkers (P > 0.05); respectively.
The frequencies of T and C alleles were 74.2% and 25.8%
in nondrinkers, and 76.2% and 23.8% in drinkers (P >
0.05); respectively. There was also no significant difference
in the genotypic and allelic frequencies between males and
females in both groups (P > 0.05 for all).
Table 1 The general characteristics and serum lipid levels in the nondrinkers and drinkers
Parameter Nondrinker
(n = 685)
Drinker
(n = 497)
t (c
2) P
Male/female 187/498 362/135 239.775 0.000
Age (years) 39.80 ± 16.37 44.93 ± 13.79 -5.691 0.000
Height (cm) 152.03 ± 7.75 155.34 ± 7.82 -7.181 0.000
Weight (kg) 51.05 ± 7.88 54.74 ± 8.21 -7.763 0.000
Body mass index (kg/m
2) 22.04 ± 2.57 22.67 ± 2.91 -3.894 0.000
Waist circumference (cm) 69.80 ± 7.17 74.69 ± 7.09 -11.657 0.000
Systolic blood pressure (mmHg) 118.33 ± 16.94 122.79 ± 16.85 -4.475 0.000
Diastolic blood pressure (mmHg) 74.57 ± 9.82 77.70 ± 10.01 -5.357 0.000
Pulse pressure (mmHg) 43.76 ± 11.78 45.10 ± 12.74 -1.842 0.066
Cigarette smoking [n (%)]
Nonsmoker 682 (89.2) 225 (45.3)
< 20 cigarettes/day 34 (4.4) 120 (24.1)
≥ 20 cigarettes/day 49 (6.4) 152 (30.6) 287.105 0.000
Alcohol consumption [n (%)]
Nondrinker 685 (100.0) -
< 25 g/day - 380 (76.6)
≥ 25 g/day - 116 (23.4)
Total cholesterol (mmol/L) 4.53 ± 0.94 4.57 ± 1.07 -0.712 0.477
Triglyceride (mmol/L) 0.98 (0.59) 1.02 (0.77) -2.923 0.003
HDL-C (mmol/L) 1.77 ± 0.47 1.83 ± 0.47 -2.102 0.036
LDL-C (mmol/L) 2.61 ± 0.72 2.56 ± 0.82 1.187 0.235
Apolipoprotein (Apo) A1 (g/L) 1.33 ± 0.27 1.41 ± 0.30 -4.928 0.000
ApoB (g/L) 0.87 ± 0.22 0.86 ± 0.23 0.806 0.420
ApoA1/ApoB 1.60 ± 0.49 1.77 ± 0.77 -4.600 0.000
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. The value of triglyceride was presented as median (interquartile range).
The difference between the two groups was determined by the Wilcoxon-Mann-Whitney test.
Table 2 Genotypic and allelic frequencies of the PPARD +294T > C polymorphism in the nondrinkers and drinkers
[n (%)]
Group n Genotype Allele
TT TC CC T C
Nondrinker 685 384 (56.0) 249 (36.4) 52 (7.6) 1017 (74.2) 353 (25.8)
Drinker 497 284 (57.2) 189 (38.0) 24 (4.8) 757 (76.2) 237 (23.8)
c
2 - 3.697 1.138
P - 0.158 0.286
Nondrinker
Male 187 105 (56.2) 68 (36.4) 14 (7.4) 278 (74.3) 96 (25.7)
Female 498 279 (56.0) 181 (36.4) 38 (7.6) 739 (74.2) 257 (25.8)
c
2 - 0.004 0.003
P - 0.998 0.959
Drinker
Male 362 210 (58.0) 136 (37.6) 16 (4.4) 556 (76.8) 168 (23.2)
Female 135 74 (54.8) 53 (39.2) 8 (6.0) 201 (74.4) 69 (25.6)
c
2 - 0.712 0.599
P - 0.701 0.438
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were different among the three genotypes (P = 0.01), the
C allele carriers had higher serum TC levels than the C
allele noncarriers. There was no significant difference in
the remaining serum lipid parameters among the three
genotypes in nondrinkers (P > 0.05 for all).
The levels of all seven lipid traits in drinkers were not
different among the three genotypes (P > 0.05 for all).
Interactions between genotypes and alcohol on serum
lipid parameters
The interaction between PPARD +294T > C genotypes
and alcohol consumption on serum TC levels (F =
0.706, P=0.494) and the remaining serum lipid para-
meters was not detected by using a factorial regression
analysis after controlling for potential confounders.
Correlation between serum lipid parameters and
genotypes
Multiple linear regression analysis showed that serum
TC, HDL-C, LDL-C, ApoA1, and ApoB levels were
correlated with genotypes in drinkers but not in non-
drinkers (P < 0.05-0.01; Table 4).
Discussion
The present study showed that the levels of serum TG,
HDL-C, ApoA1, and the ratio of ApoA1 to ApoB were
higher in drinkers than in nondrinkers. There were no
significant differences in the levels of TC, LDL-C and
ApoB between the two groups. These results suggest
that the great majority of our study populations are ben-
eficial from alcohol consumption. Low to middle
amounts of alcohol when taken on a regular basis have
been shown to protect against CAD and death [12,13].
A moderate intake of alcohol is associated with protec-
tion against CAD, probably due in part to a dose-depen-
dent increase in HDL-C and ApoA1 levels [14-17].
According to a previous meta-analysis, a daily dose of
30 g alcohol results in an average HDL-C level rise of
3.99 mg/dl, and an ApoA1 level rise of 8.82 mg/dl [14].
The harmful effects of heavy alcohol consumption on
serum lipid profiles may be due to an increase in plasma
TG levels [14,18]. In the previous meta-analysis, 30 g of
Table 3 Genotypes of the PPARD +294T > C polymorphism and serum lipid levels in the nondrinkers and drinkers
Group Genotype n TC
(mmol/L)
TG
(mmol/L)
HDL-C
(mmol/L)
LDL-C
(mmol/L)
ApoA1
(g/L)
ApoB
(g/L)
ApoA1/
ApoB
Nondrinker TT 384 4.44 ± 0.91 0.98(0.57) 1.74 ± 0.44 2.57 ± 0.70 1.31 ± 0.26 0.86 ± 0.21 1.60 ± 0.43
TC 249 4.62 ± 0.92 0.99(0.65) 1.80 ± 0.48 2.64 ± 0.71 1.35 ± 0.26 0.90 ± 0.24 1.59 ± 0.48
CC 52 4.74 ± 1.12 0.89(0.57) 1.87 ± 0.54 2.77 ± 0.92 1.39 ± 0.30 0.91 ± 0.24 1.68 ± 0.88
F - - 4.629 0.217 2.667 2.301 2.545 2.810 0.734
P - - 0.010 0.897 0.070 0.101 0.079 0.061 0.480
Drinker TT 284 4.57 ± 1.01 1.01(0.71) 1.83 ± 0.49 2.60 ± 0.82 1.41 ± 0.32 0.86 ± 0.23 1.77 ± 0.78
TC 189 4.55 ± 1.16 1.02(0.89) 1.85 ± 0.46 2.47 ± 0.79 1.42 ± 0.28 0.86 ± 0.25 1.79 ± 0.69
CC 24 4.74 ± 1.08 1.26(0.93) 1.68 ± 0.43 2.73 ± 0.97 1.38 ± 0.31 0.93 ± 0.28 1.67 ± 0.94
F - - 0.355 3.836 1.365 2.189 0.184 1.205 0.300
P - - 0.702 0.147 0.256 0.113 0.832 0.301 0.741
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoA1, apolipoprotein A1; ApoB,
apolipoprotein B; ApoA1/ApoB, the ratio of apolipoprotein A1 to apolipoprotein B. The value of TG was presented as median (interquartile range). The difference
among the genotypes was determined by the Kruskal-Wallis test.
Table 4 Correlation between serum lipid parameters and the PPARD +294T > C genotypes in the nondrinkers and
drinkers
Lipid Relative factor Unstandardized coefficient Standard error Standardized coefficient tP
Nondrinker plus drinker
TC Genotype 0.123 0.046 0.080 2.833 0.005
ApoB Genotype 0.025 0.010 0.071 2.527 0.012
Drinker
TC Genotype 0.167 0.055 0.113 3.058 0.002
HDL-C Genotype 0.068 0.028 0.092 2.440 0.015
LDL-C Genotype 0.089 0.042 0.078 2.110 0.035
ApoA1 Genotype 0.036 0.016 0.086 2.279 0.023
ApoB Genotype 0.030 0.013 0.086 2.336 0.020
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of 5.69 mg/dl [14]. The alcohol intake of 60 g/day
increases the TG levels by about 0.19 mg/dl per 1 gram
of alcohol consumed [18]. The effects of alcohol con-
sumption on LDL-C are inconsistent. A recent study in
older Italian subjects (65-84 years old) has found that
alcohol intake increases serum LDL-C levels [41].
Another recent study of Turks also found increases in
LDL-C, as well as in ApoB and TG, with alcohol in
men, while women had decreased TG and no change in
LDL-C or ApoB with alcohol [42]. A decrease in LDL-C
with increased alcohol intake has also been reported in
some studies, but this effect is less consistent and prob-
ably depends on the combination of one or more
unmeasured factors [17].
The genotypic and allelic frequencies of PPARD
+294T > C polymorphism were different in diverse
populations. Several previous studies have showed that
the frequency of the rare allele (+294C) was 18.3% in
Russian endurance-oriented athletes and 12.1% in con-
trols (P < 0.0001) [43], 32.0% in Tunisian CAD patients
and 18.9% in healthy volunteers (P = 0.001) [32], and
30.8% in Chinese CAD patients and 19.5% in normal
controls (P < 0.05) [33]. Other studies, however, showed
that there was no difference in its frequency between
the patients with type 2 diabetes and the non-diabetic
controls (18.7% vs 19.2%) [35], or among the patients
with metabolic syndrome, essential hypertension and
type 2 diabetes [26]. In the present study, we showed
that the frequency of +294C alleles was 25.8% in non-
drinkers, and 23.8% in drinkers (P > 0.05). There was no
significant difference in the genotypic and allelic fre-
quencies between males and females in both groups.
However, the frequency of PPARD +294C allele was
higher in our study population than in 543 healthy 50-
year-old-men (15.6%) from the northern part of the
greater Stockholm area [24], in normal controls (19.5%)
from Chinese Anhui Province [33], in healthy Tunisian
population (18.9%) [32], and in non-diabetic Germany
controls (19.2%) [35]; but it was lower than in Tunisian
CAD patients (32.0%) [32] and Chinese CAD patients
(30.8%) [33]. These results indicate that the prevalence
of the C allele variants of PPARD +294T > C poly-
morphism may have an ethnic or disease specificity.
The association of PPARD +294T > C polymorphism
and serum lipid levels is inconsistent. Skogsberg et al.
[24] demonstrated that homozygotes for the rare C
allele had a higher LDL-C concentration than homozy-
gotes for the common T allele. There were no associa-
tions with the HDL-C levels. In another study in
Scottish men, they found that the +294C allele did not
influence LDL-C concentrations but was associated with
lower HDL-C levels [25]. Aberle et al. [27] also showed
a highly significant association between the rare C allele
and lower HDL-C levels in dyslipidemic female subjects.
In addition, metabolic syndrome patients with CC geno-
type had significantly higher TC and LDL-C levels than
those with TT and TC genotypes [26]. The PPARD
+294T > C polymorphism was associated with HDL-C
and was dependent on sex among subjects with and
without type 2 diabetes [29]. The risk variant of PPARD
+294T > C marker was associated with higher LDL-C
and increased serum TC [31]. However, Gouni-Berthold
et al. [35] found that the presence of the C allele had
no effect on TG, HDL-C, and LDL-C levels, both in dia-
betic and non-diabetic German controls, or both in men
and in women. The same result was found by Jguirim-
Souissi et al. [32] both in CAD patients and healthy
controls. In the present study, we showed that the levels
of TC in nondrinkers were different among the three
genotypes, the C allele carriers had higher serum TC
levels than the C allele noncarriers. But the levels of all
seven lipid traits in drinkers were not different among
the three genotypes. Serum TC, HDL-C, LDL-C,
ApoA1, and ApoB levels were correlated with genotypes
in drinkers but not in nondrinkers. These results suggest
that the effects of PPARD +294T > C polymorphism on
serum lipid levels are different between nondrinkers and
drinkers.
The interactions between PPARD +294T > C poly-
morphism and alcohol consumption on serum lipid
levels have not been previously explored. In a previous
study, Brand-Herrmann et al. [9] showed that alcohol
consumption modulates the relation between the PPAR-
gamma 2 (PPARG) Pro12Ala and HDL-C. They ran-
domly recruited 251 nuclear families (433 parents and
493 offspring) in the framework of the European Project
on Genes in Hypertension study and genotyped 926 par-
ticipants in whom all serum lipid variables and informa-
tion on alcohol consumption were available for PPAR-
gamma 2 Pro12Ala. The results showed that the Ala12
allele was more frequent in Novosibirsk (17%) than in
Cracow (12%) and Mirano (11%, P < 0.01). Italian off-
spring carrying the Ala12 allele had higher serum HDL-
C than noncarriers (P < 0.05). HDL-C levels were on
average 0.086 mmol/L (P = 0.001) higher in drinkers
than in nondrinkers. As compared with Pro12 homozy-
gotes, Ala12 allele carriers consuming alcohol had
higher serum total and HDL-C, with the opposite trend
occurring in nondrinkers. This genotype-alcohol interac-
tion was independent of the type of alcoholic beverage
and more pronounced in moderate than in heavy drin-
kers. In the present study, however, we found no inter-
action between the PPARD +294T > C genotypes and
alcohol consumption on serum lipid levels in the drin-
kers. These findings suggest that increased levels of TG,
HDL-C, ApoA1, and the ratio of ApoA1 to ApoB in
drinkers were not influenced by the interactions of
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sumption. The effect of different kinds of wine on
serum lipid profiles is not well known. In the present
study, 90% of the wine drunk by the subjects was corn
wine, rice wine or rum, in which the alcohol content is
low. Thus, the effects of different kinds of alcohol con-
sumption on serum lipid levels still need to be deter-
mined [44,45].
Conclusion
The present study shows that the levels of TG, HDL-C,
ApoA1, and the ratio of ApoA1 to ApoB were higher in
drinkers than in nondrinkers. There were no significant
differences in the levels of TC, LDL-C and ApoB, and the
genotypic and allelic frequencies of PPARD +294T > C
between nondrinkers and drinkers. The levels of TC in
nondrinkers were different among the three genotypes,
the C allele carriers had higher serum TC levels than the
C allele noncarriers, whereas the levels of all seven lipid
traits in drinkers were not different among the three gen-
otypes. The interaction of PPARD +294T > C genotypes
and alcohol consumption on serum TC levels and the
remaining serum lipid parameters was not detected in
the drinkers. Multiple linear regression analysis showed
that serum TC, HDL-C, LDL-C, ApoA1, and ApoB levels
were correlated with genotypes in drinkers but not in
nondrinkers. These results suggest that the great majority
of our study populations are beneficial from alcohol con-
sumption. But there is no interaction between the
PPARD +294T > C genotypes and alcohol consumption
on serum lipid levels in the drinkers.
Acknowledgements
This study was supported by the National Natural Science Foundation of
China (No: 30660061)
Author details
1Department of Cardiology, Institute of Cardiovascular Diseases, the First
Affiliated Hospital, Guangxi Medical University, 22 Shuangyong Road,
Nanning 530021, Guangxi, People’s Republic of China.
2Department of
Anatomy, School of Premedical Sciences, Guangxi Medical University,
Nanning 530021, Guangxi, People’s Republic of China.
Authors’ contributions
XLW participated in the design, helped to carry out the genotyping, and
drafted the manuscript. LM undertook genotyping. DFW collaborated to the
genotyping and performed the statistical analyses. RXY conceived the study,
participated in the design, carried out the epidemiological survey, collected
the samples, and helped to draft the manuscript. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 16 November 2011 Accepted: 23 December 2011
Published: 23 December 2011
References
1. Austin MA, Hokanson JE, Edwards KL: Hypertriglyceridemia as a
cardiovascular risk factor. Am J Cardiol 1998, 81:7B-12B.
2. Castelli WP, Anderson K, Wilson PW, Levy D: Lipids and risk of coronary
heart disease. The Framingham Study. Ann Epidemiol 1992, 2:23-8.
3. Brunzell JD, Sniderman AD, Albers JJ, Kwiterovich PO Jr: Apoproteins B and
A-I and coronary artery disease in humans. Arteriosclerosis 1984, 4:79-83.
4. Holewijn S, den Heijer M, Swinkels DW, Stalenhoef AFH, de Graaf J:
Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for
identifying individuals at increased cardiovascular risk. J Intern Med 2010,
268:567-77.
5. Ruixing Y, Qiming F, Dezhai Y, Shuquan L, Weixiong L, Shangling P, Hai W,
Yongzhong Y, Feng H, Shuming Q: Comparison of demography, diet,
lifestyle, and serum lipid levels between the Guangxi Bai Ku Yao and
Han populations. J Lipid Res 2007, 48:2673-81.
6. Ruixing Y, Dezhai Y, Shuquan L, Yuming C, Hanjun Y, Qiming F,
Shangling P, Weixiong L, Jing T, Yiyang L: Hyperlipidaemia and its risk
factors in the Guangxi Bai Ku Yao and Han populations. Public Health
Nutr 2009, 12:816-24.
7. Ruixing Y, Yiyang L, Meng L, Kela L, Xingjiang L, Lin Z, Wanying L,
Jinzhen W, Dezhai Y, Weixiong L: Interactions of the apolipoprotein C-III
3238C > G polymorphism and alcohol consumption on serum
triglyceride levels. Lipids Health Dis 2010, 9:86.
8. Tai ES, Corella D, Demissie S, Cupples LA, Coltell O, Schaefer EJ, Tucker KL,
Ordovas JM, Framingham heart study: Polyunsaturated fatty acids interact
with the PPARA-L162V polymorphism to affect plasma triglyceride and
apolipoprotein C-III concentrations in the Framingham Heart Study. J
Nutr 2005, 135:397-403.
9. Brand-Herrmann SM, Kuznetsova T, Wiechert A, Stolarz K, Tikhonoff V,
Schmidt-Petersen K, Telgmann R, Casiglia E, Wang JG, Thijs L, Staessen JA,
Brand E, European Project on Genes in Hypertension Investigators: Alcohol
intake modulates the genetic association between HDL cholesterol and
the PPARgamma2 Pro12Ala polymorphism. J Lipid Res 2005, 46:913-9.
10. Robitaille J, Gaudet D, Pérusse L, Vohl MC: Features of the metabolic
syndrome are modulated by an interaction between the peroxisome
proliferator-activated receptor-delta -87T > C polymorphism and dietary
fat in French-Canadians. Int J Obes (Lond) 2007, 31:411-7.
11. Doll R, Peto R, Hall E, Wheatley K, Gray R: Mortality in relation to
consumption of alcohol. BMJ 1994, 309:911-8.
12. Camargo CA Jr, Hennekens CH, Gaziano JM, Glynn RJ, Manson JE,
Stampfer MJ: Prospective study of moderate alcohol consumption and
mortality in US male physicians. Arch Intern Med 1997, 157:79-85.
13. Choudhury SR, Ueshima H, Kita Y, Kobayashi KM, Okayama A, Yamakawa M,
Hirao Y, Ishikawa M, Miyoshi Y: Alcohol intake and serum lipids in a
Japanese population. Int J Epidemiol 1994, 23:940-7.
14. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ: Moderate alcohol
intake and lower coronary heart disease: meta-analysis of effects on
lipids and haemostatic factors. BMJ 1999, 319:1523-8.
15. De Oliveira E, Silva ER, Foster D, McGee Harper M, Seidman CE, Smith JD,
Breslow JL, Brinton EA: Alcohol consumption raises HDL cholesterol levels
by increasing the transport rate of apolipoproteins A-I and A-II.
Circulation 2000, 102:2347-52.
16. Agarwal DP: Cardioprotective effects of light-moderate consumption of
alcohol: a review of putative mechanisms. Alcohol Alcohol 2002,
37:409-15.
17. Savolainen MJ, Kesaniemi YA: Effects of alcohol lipoproteins in relation to
coronary heart disease. Curr Opin Lipidol 1995, 6:243-50.
18. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM,
Hennekens CH: A prospective study of trigliceryde level, low-density
lipoprotein particle diameter, and risk of myocardial infarction. JAMA
1996, 276:882-8.
19. Kamon J, Yamauchi T, Kadowaki T: PPAR family (PPAR alpha, PPAR delta,
PPAR gamma). Nihon Rinsho 2002, 60:S593-S600.
20. Reddy JK, Hashimoto T: Peroxisomal beta-oxidation and peroxisome
proliferator-activated receptor alpha: an adaptive metabolic system.
Annu Rev Nutr 2001, 21:193-230.
21. Spiegelman BM, Flier JS: Adipogenesis and obesity: rounding out the big
picture. Cell 1996, 87:377-89.
22. Skogsberg J, Kannisto K, Roshani L, Gagne E, Hamsten A, Larsson C,
Ehrenborg E: Characterization of the human peroxisome proliferator
activated receptor delta gene and its expression. Int J Mol Med 2000, 6:73-81.
23. Yoshikawa T, Brkanac Z, Dupont BR, Xing GQ, Leach RJ, Detera-
Wadleigh SD: Assignment of the human nuclear hormone receptor, UC1
(PPARD), to chromosome 6p21.1-p21.2. Genomics 1996, 35:637-8.
Wei et al. Lipids in Health and Disease 2011, 10:242
http://www.lipidworld.com/content/10/1/242
Page 7 of 824. Skogsberg J, Kannisto K, Cassel TN, Hamsten A, Eriksson P, Ehrenborg E:
Evidence that peroxisome proliferator-activated receptor delta
influences cholesterol metabolism in men. Arterioscler Thromb Vasc Biol
2003, 23:637-43.
25. Skogsberg J, McMahon AD, Karpe F, Hamsten A, Packard CJ, Ehrenborg E,
West of Scotland Coronary Prevention Study: Peroxisome proliferator
activated receptor delta genotype in relation to cardiovascular risk
factors and risk of coronary heart disease in hypercholesterolaemic men.
J Intern Med 2003, 254:597-604.
26. Yan ZC, Shen CY, Zhong J, Wang L, Ni YX, Nie H, Zhu ZM: PPARdelta +
294T/C gene polymorphism related to plasma lipid, obesity and left
ventricular hypertrophy in subjects with metabolic syndrome. Zhonghua
Xin Xue Guan Bing Za Zhi 2005, 33:529-33.
27. Aberle J, Hopfer I, Beil FU, Seedorf U: Association of the T+294C
polymorphism in PPAR delta with low HDL cholesterol and coronary
heart disease risk in women. Int J Med Sci 2006, 3:108-11.
28. Hautala AJ, Leon AS, Skinner JS, Rao DC, Bouchard C, Rankinen T:
Peroxisome proliferator-activated receptor-delta polymorphisms are
associated with physical performance and plasma lipids: the HERITAGE
Family Study. Am J Physiol Heart Circ Physiol 2007, 292:H2498-505.
29. Burch LR, Donnelly LA, Doney AS, Brady J, Tommasi AM, Whitley AL,
Goddard C, Morris AD, Hansen MK, Palmer CN: Peroxisome proliferator-
activated receptor-delta genotype influences metabolic phenotype and
may influence lipid response to statin therapy in humans: a genetics of
diabetes audit and research Tayside study. J Clin Endocrinol Metab 2010,
95:1830-7.
30. Miao L, Yin RX, Wu DF, Cao XL, Li Q, Hu XJ, Yan TT, Aung LH, Yang DZ,
Lin WX: Peroxisome proliferator-activated receptor delta +294T > C
polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and
Han populations. Lipids Health Dis 2010, 9:145.
31. Nikitin AG, Chistiakov DA, Minushkina LO, Zateyshchikov DA, Nosikov VV:
Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants
with coronary artery disease and metabolic risk factors of coronary
atherosclerosis in a Russian population. Heart Vessels 2010, 25:229-36.
32. Jguirim-Souissi I, Jelassi A, Hrira Y, Najah M, Slimani A, Addad F, Hassine M,
Hamda KB, Maatouk F, Rouis M, Slimane MN: +294T/C polymorphism in
the PPAR-delta gene is associated with risk of coronary artery disease in
normolipidemic Tunisians. Genet Mol Res 2010, 9:1326-33.
33. Wang LF, Tan M, Chang H, Yu H, Shen JJ: Relationship of peroxisome
proliferation-activated receptor-delta +294 T/C gene polymorphism with
coronary artery disease. Acta Univ Med Anhui 2008, 43:701-5.
34. Holzapfel J, Heun R, Lütjohann D, Jessen F, Maier W, Kölsch H: PPARD
haplotype influences cholesterol metabolism but is no risk factor of
Alzheimer’s disease. Neurosci Lett 2006, 408:57-61.
35. Gouni-Berthold I, Giannakidou E, Faust M, Berthold HK, Krone W: The
peroxisome proliferator-activated receptor delta +294T/C polymorphism
in relation to lipoprotein metabolism in patients with diabetes mellitus
type 2 and in non-diabetic controls. Atherosclerosis 2005, 183:336-41.
36. People’s Republic of China-United States Cardiovascular and
Cardiopulmonary Epidemiology Research Group: An epidemiological study
of cardiovascular and cardiopulmonary disease risk factors in four
populations in the People’s Republic of China. Baseline report from the
P.R.C.-U.S.A. Collaborative Study. Circulation 1992, 85:1083-96.
37. Ruixing Y, Weixiong L, Hanjun Y, Dezhai Y, Shuquan L, Shangling P,
Qiming F, Jinzhen W, Jianting G, Yaju D: Diet, lifestyle, and blood pressure
of the middle-aged and elderly in the Guangxi Bai Ku Yao and Han
populations. Am J Hypertens 2008, 21:382-7.
38. Ruixing Y, Shangling P, Shuquan L, Dezhai Y, Weixiong L, Qiming F,
Yuming C, Yaoheng H, Yijiang Z, Qinchen L: Comparison of hypertension
and its risk factors between the Guangxi Bai Ku Yao and Han
populations. Blood Press 2008, 17:306-16.
39. Cooperative Meta-analysis Group of China Obesity Task Force: Predictive
values of body mass index and waist circumference to risk factors of
related diseases in Chinese adult population. Chin J Epidemiol 2002,
23:5-10.
40. Akhmetov II, Astranenkova IV, Rogozkin VA: Association of PPARD gene
polymorphism with human physical performance. Mol Biol (Mosk) 2007,
41:852-7.
41. Perissinotto E, Buja A, Maggi S, Enzi G, Manzato E, Scafato E, Mastrangelo G,
Frigo AC, Coin A, Crepaldi G, Sergi G, ILSA Working Group: Alcohol
consumption and cardiovascular risk factors in older lifelong wine
drinkers: the Italian Longitudinal Study on Aging. Nutr Metab Cardiovasc
Dis 2010, 20:647-55.
42. Onat A, Hergenc G, Dursunoglu D, Ordu S, Can G, Bulur S, Yüksel H:
Associations of alcohol consumption with blood pressure, lipoproteins,
and subclinical inflammation among Turks. Alcohol 2008, 42:593-601.
43. Akhmetov II, Astranenkova IV, Rogozkin VA: Association of PPARD gene
polymorphism with human physical performance. Mol Biol (Mosk) 2007,
41:852-7.
44. Ruixing Y, Shangling P, Hong C, Hanjun Y, Hai W, Yuming C, Jinzhen W,
Feng H, Meng L, Muyan L: Diet, alcohol consumption, and serum lipid
levels of the middle-aged and elderly in the Guangxi Bai Ku Yao and
Han populations. Alcohol 2008, 42:219-29.
45. Ruixing Y, Jinzhen W, Yaoheng H, Jing T, Hai W, Muyan L, Yiyang L,
Dongmei F, Hanjun Y, Yuming C: Associations of diet and lifestyle with
hyperlipidemia for middle-aged and elderly persons among the Guangxi
Bai Ku Yao and Han populations. J Am Diet Assoc 2008, 108:970-6.
doi:10.1186/1476-511X-10-242
Cite this article as: Wei et al.: The peroxisome proliferator-activated
receptor delta +294T > C polymorphism and alcohol consumption on
serum lipid levels. Lipids in Health and Disease 2011 10:242.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Wei et al. Lipids in Health and Disease 2011, 10:242
http://www.lipidworld.com/content/10/1/242
Page 8 of 8